Marshall Wace North America L.P. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 78 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,506,000
+542.8%
871,574
+349.9%
0.02%
+533.3%
Q4 2019$701,000
-14.1%
193,741
+20.4%
0.00%
-40.0%
Q2 2018$816,000
-66.6%
160,878
-55.1%
0.01%
-58.3%
Q1 2018$2,446,000
+2274.8%
358,687
+1992.8%
0.01%
+1100.0%
Q3 2017$103,00017,1390.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders